Valuation: RAMM Pharma Corp.

Market Cap 1.19M 844K 739K 681K 629K 80.53M 1.21M 8.14M 3.2M 39.67M 3.17M 3.1M 136M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 470K 333K 291K 268K 248K 31.73M 478K 3.21M 1.26M 15.63M 1.25M 1.22M 53.74M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2019-09-30
Director of Finance/CFO - 2022-12-08
Director TitleAgeSince
Director/Board Member - 2019-09-30
Director/Board Member 82 2019-09-30
Director/Board Member 66 2019-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-76.29%-92.33% - - 844K
-2.33%-2.09%+49.88%+169.76% 1,060B
-0.82%-2.30%+63.79%+62.56% 619B
-0.73%-4.98%+28.91%+83.79% 438B
+0.33%-1.17%+31.07%+26.57% 333B
-0.02%-2.85%+29.15%+46.14% 282B
-3.89%-11.22%+22.81%+25.23% 267B
+0.66%-1.42%-26.59%-37.67% 218B
-0.06%-2.88%+23.07%+61.02% 196B
-3.72%-1.10%+18.41%+69.98% 161B
Average -8.69%-3.33%+26.72%+56.38% 397.1B
Weighted average by Cap. -1.31%-3.10%+36.75%+83.66%

Financials

2024 2025
Net sales 4.34M 3.07M 2.69M 2.48M 2.29M 293M 4.42M 29.6M 11.63M 144M 11.53M 11.28M 496M 3.36M 2.38M 2.08M 1.92M 1.77M 227M 3.42M 22.91M 9M 112M 8.92M 8.73M 384M
Net income -16.5M -11.67M -10.21M -9.42M -8.7M -1.11B -16.78M -113M -44.18M -548M -43.82M -42.87M -1.89B -8.91M -6.3M -5.51M -5.08M -4.7M -601M -9.06M -60.75M -23.86M -296M -23.66M -23.15M -1.02B
Net Debt -626K -443K -387K -357K -330K -42.21M -636K -4.27M -1.68M -20.79M -1.66M -1.63M -71.48M -723K -512K -448K -413K -381K -48.8M -736K -4.93M -1.94M -24.04M -1.92M -1.88M -82.65M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-